A new concept for the research antibody market:
Our mission is to eradicate wasted R&D expenses caused by poorly characterised, unstable, inconsistently performing, or no longer available immunological reagents. Among the large amounts of commercially available antibodies to any one specific protein/biomarker, we identify those few that meet the highest quality standards. The information on the manufacturer’s product sheet is thoroughly scrutinised. We use proprietary selection criteria, known as Aeonian Rating®, to identify the best candidate antibodies.
Based on this concept, we offer the selected antibodies from the original manufacturers in our catalogue. In addition, we offer custom services to select the right antibody from the market according to the customer’s specific requirements and under strict confidentiality.